For the year ending 2025-12-31, PTHS has $130,397K in assets. $91,516K in debts. $17,973K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 17,973 | |||
| Restricted cash, current | 50 | |||
| Accounts receivable, net | 8,858 | |||
| Inventory, net | 23,574 | |||
| Prepaid expenses and other current assets | 2,955 | |||
| Total current assets | 53,410 | |||
| Property and equipment, net | 9,586 | |||
| Operating lease right-of-use assets, net | 3,250 | |||
| 2026 | 4,174 | |||
| 2027 | 4,174 | |||
| 2028 | 3,965 | |||
| 2029 | 3,830 | |||
| 2030 | 3,822 | |||
| 2031 and thereafter | 19,505 | |||
| Intangible assets, net | 39,470 | |||
| Goodwill | 24,681 | |||
| Total assets | 130,397 | |||
| Accounts payable | 2,986 | |||
| Accrued expenses | 15,364 | |||
| Contingent consideration | 2,200 | |||
| Operating lease liabilities, current portion | 635 | |||
| Deferred revenue, current portion | 966 | |||
| Loan payable, net of debt discount-Nonrelated Party | 0 | |||
| Loan payable, net of debt discount-Related Party | 0 | |||
| Other liabilities | 3,842 | |||
| Total current liabilities | 25,993 | |||
| Operating lease liabilities, net of current portion | 2,752 | |||
| Deferred revenue, net of current portion | 1,280 | |||
| Convertible debt | 31,441 | |||
| Other long-term liabilities | 30,050 | |||
| Total liabilities | 91,516 | |||
| Preferred stock, value-Series APreferred Stock | 0 | |||
| Preferred stock, value-Series CPreferred Stock | 0 | |||
| Common stock, value | 0 | |||
| Additional paid in capital | 103,675 | |||
| Accumulated deficit | -64,794 | |||
| Total stockholders' equity (deficit) | 38,881 | |||
| Total liabilities and stockholders' equity (deficit) | 130,397 | |||
Pelthos Therapeutics Inc. (PTHS)
Pelthos Therapeutics Inc. (PTHS)